Organogenesis Holding (ORGO) Reports In-Line Q2 EPS, beats revenue

Organogenesis Holding (NASDAQ: ORGO) reported Q2 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $117.3 million versus the consensus estimate of $115.09 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c